We are live on
!
Find out more
Fortress Biotech
FBIO
FBIO
48 hedge funds and large institutions have $24M invested in Fortress Biotech in 2017 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 14 increasing their positions, 16 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
32% more capital invested
Capital invested by funds: $18.1M → $24M (+$5.86M)
0.06% less ownership
Funds ownership: 0.91% → 0.86% (-0.06%)
6% less funds holding
Funds holding: 51 → 48 (-3)
13% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 16
Holders
48
Holders Change
-3
Holders Change %
-5.88%
% of All Funds
1.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
14
Reduced
16
Closed
4
Calls
$80K
Puts
–
Net Calls
+$80K
Net Calls Change
-$194K
Top Buyers
| 1 |
BlackRock
New York
|
+$4.72M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$202K |
| 3 |
State Street
Boston,
Massachusetts
|
+$200K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$152K |
| 5 |
JP Morgan Chase
New York
|
+$67.4K |
Top Sellers
| 1 |
ACA
Avoro Capital Advisors
New York
|
-$607K |
| 2 |
Millennium Management
New York
|
-$323K |
| 3 |
Morgan Stanley
New York
|
-$182K |
| 4 |
Citigroup
New York
|
-$102K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$74.4K |
